Abstract:Purpose: To conduct the fusion of radiomics and deep transfer learning features from the intratumoral and peritumoral areas in breast DCE-MRI images to differentiate between benign and malignant breast tumors, and to compare the diagnostic accuracy of this fusion model against the assessments made by experienced radiologists. Materials and methods: This multi-center study conducted a retrospective analysis of DCE-MRI images from 330 women diagnosed with breast cancer, with 138 cases categorized as benign and 192 as malignant. The training and internal testing sets comprised 270 patients from center 1, while the external testing cohort consisted of 60 patients from center 2. A fusion feature set consisting of radiomics features and deep transfer learning features was constructed from both intratumoral (ITR) and peritumoral (PTR) areas. The Least absolute shrinkage and selection operator (LASSO) based support vector machine was chosen as the classifier by comparing its performance with five other machine learning models. The diagnostic performance and clinical usefulness of fusion model were verified and assessed through the area under the receiver operating characteristics (ROC) and decision curve analysis. Additionally, the performance of the fusion model was compared with the diagnostic assessments of two experienced radiologists to evaluate its relative accuracy. The study strictly adhered to CLEAR and METRICS guidelines for standardization to ensure rigorous and reproducible methods. Results: The findings show that the fusion model, utilizing radiomics and deep transfer learning features from the ITR and PTR, exhibited exceptional performance in classifying breast tumors, achieving AUCs of 0.950 in the internal testing set and 0.921 in the external testing set. This performance significantly surpasses that of models relying on singular regional radiomics or deep transfer learning features alone. Moreover, the fusion model demonstrated superior diagnostic accuracy compared to the evaluations conducted by two experienced radiologists, thereby highlighting its potential to support and enhance clinical decision-making in the differentiation of benign and malignant breast tumors. Conclusion: The fusion model, combining multi-regional radiomics with deep transfer learning features, not only accurately differentiates between benign and malignant breast tumors but also outperforms the diagnostic assessments made by experienced radiologists. This underscores the model's potential as a valuable tool for improving the accuracy and reliability of breast tumor diagnosis.

Whole tumour- and subregion-based radiomics of contrast-enhanced mammography in differentiating HER2 expression status of invasive breast cancers: A double-centre pilot study

Enhancing Early Breast Cancer Diagnosis with Contrast-Enhanced Ultrasound Radiomics: Insights from Intratumoral and Peritumoral Analysis

Intra- and Peritumoral Radiomics on Assessment of Breast Cancer Molecular Subtypes Based on Mammography and MRI.

Intra- and Peritumoral Radiomics of Contrast-Enhanced Mammography Predicts Axillary Lymph Node Metastasis in Patients with Breast Cancer: A Multicenter Study.

A New Application of Multimodality Radiomics Improves Diagnostic Accuracy of Nonpalpable Breast Lesions in Patients with Microcalcifications-Only in Mammography

Insights from Contrast-Enhanced Mammography (CEM)

Identifying Triple-Negative Breast Cancer Using Background Parenchymal Enhancement Heterogeneity on Dynamic Contrast-Enhanced MRI: A Pilot Radiomics Study

Conventional ultrasound and contrast-enhanced ultrasound radiomics in breast cancer and molecular subtype diagnosis

Multiparametric MRI Radiomics With Machine Learning for Differentiating HER2-Zero, -Low, and -Positive Breast Cancer: Model Development, Testing, and Interpretability Analysis

Potential of the Non-Contrast-Enhanced Chest CT Radiomics to Distinguish Molecular Subtypes of Breast Cancer: A Retrospective Study

Preliminary study on DCE-MRI radiomics analysis for differentiation of HER2-low and HER2-zero breast cancer

Radiomic Analysis of Imaging Heterogeneity in Tumours and the Surrounding Parenchyma Based on Unsupervised Decomposition of DCE-MRI for Predicting Molecular Subtypes of Breast Cancer.

Prediction Breast Molecular Typing of Invasive Ductal Carcinoma Based on Dynamic Contrast Enhancement Magnetic Resonance Imaging Radiomics Characteristics: A Feasibility Study

Intra- and peritumoral radiomics features based on multicenter automatic breast volume scanner for noninvasive and preoperative prediction of HER2 status in breast cancer: a model ensemble research

Radiomics in cone-beam breast CT for the prediction of axillary lymph node metastasis in breast cancer: a multi-center multi-device study

Unsupervised Analysis Based on DCE-MRI Radiomics Features Revealed Three Novel Breast Cancer Subtypes with Distinct Clinical Outcomes and Biological Characteristics

Value of Machine Learning with CE-MRI Radiomics for Early Prediction of Pathological Complete Response to Neoadjuvant Therapy in HER2-positive Invasive Breast Cancer

Diagnostic Value of Radiomics Analysis in Contrast-Enhanced Spectral Mammography for Identifying Triple-Negative Breast Cancer

Intra- and Peritumoral Radiomics Model Based on Early DCE-MRI for Preoperative Prediction of Molecular Subtypes in Invasive Ductal Breast Carcinoma: A Multitask Machine Learning Study

Integrating intratumoral and peritumoral radiomics with deep transfer learning for DCE-MRI breast lesion differentiation: A multicenter study comparing performance with radiologists